Brief: Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial
01/10/2025 14:50
Oct 1 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRICULAR TACHYCARDIA ADAGIO MEDICAL HOLDINGS INC: ANTICIPATE COMPLETION OF PMA PROCESS FOR VCLAS SYSTEM EXPECTED BY YEAR-END 2026 Source text: ID:nBw6Vz6B6a Further company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device